NCT00528125

Brief Summary

Pain prevention and/or therapy in neonates is still a challenge. It is widely accepted that early pain experience can have a tremendous impact on the pain memory. We want to investigate if a simple, fast method, that is nearly devoid of side effects can lead to a significant alleviation of pain sensation in neonates. Acupuncture has been shown to be effective in various painful conditions. Trials on acupuncture in children are rare. Trials on acupuncture in neonates are lacking so far. Our hypothesis is that neonates in the active laser group experience less pain than those in the placebo group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Sep 2007

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

September 11, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 12, 2007

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

March 29, 2018

Status Verified

March 1, 2008

Enrollment Period

4 months

First QC Date

September 11, 2007

Last Update Submit

March 27, 2018

Conditions

Keywords

pain preventionneonatal painlaser acupuncturecomplementary and alternative medicine

Outcome Measures

Primary Outcomes (1)

  • The Pain score Premature Infant Pain Profile (PIPP), according to video analysis

    The Premature Infant Pain Profile (PIPP Score) is a reliable instrument to measure acute pain in neonates and it includes objective vital parameters and is not only a third-party observation. A total of seven indicators are measured: Three behavioural indicators (facial actions: eye squeeze, brow bulge and nasolabial furrow), two physiological indicators (heart rate and oxygen saturation), and two contextual indicators (gestational age and behavioral state). A scoring of 0, 1, 2 or 3 points is used for each of the seven indicators. All indicators are summed up to a total score. Depending on the gestational age, the possible total score ranges from 18 to 21.

    5 minutes from the heel prick

Secondary Outcomes (1)

  • Cry Time

    right after after heel prick up to 5 minutes

Study Arms (2)

A

ACTIVE COMPARATOR

Active laser acupuncture

Procedure: active laser acupuncture

B

PLACEBO COMPARATOR

placebo laser acupuncture

Procedure: placebo laser acupuncture

Interventions

low level laser acupuncture, 830 nm, 30 mW, 0,3 J per acupoint, 2 points per neonate (Hegu and Shen Men). Overall 30 seconds of treatment

Also known as: Modulas Handy 2/99, schwamedico, Ehringshausen, Germany
A

placebo laser acupuncture at two acupoints (Hegu, Shen Men). Overall treatment time 30 seconds.

Also known as: placebo laser, Modulas Handy 2/99, schwamedico, Ehringshausen, Germany
B

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Neonates with no obvious underlying disease (genetic (e.g. M. Down), metabolic)and not under pain medication

You may not qualify if:

  • Older than 28 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Children Hospital Homburg

Homburg, Saarland, 66421, Germany

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sven Gottschling, MD

    University Children Hospital Homburg, Germany

    PRINCIPAL INVESTIGATOR
  • Ludwig Gortner, MD, PhD

    University Children Hospital Homburg, Germany

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 11, 2007

First Posted

September 12, 2007

Study Start

September 1, 2007

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

March 29, 2018

Record last verified: 2008-03

Locations